Malik Fady Ibraham Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
93
Insider Sells Sum
$27.58M

Insider Activity of Malik Fady Ibraham

According to the SEC Form 4 filings, Malik Fady Ibraham, being in a position of

  1. EVP Research & Development at Cytokinetics, Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 73835 shares for $5.07M,
    over all time since 2014-12-30, has bought 0 shares, and sold 713836 shares for $33.65M.

Biography of Malik Fady Ibraham

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,070,18220100

Comparison of Insiders on Amount of Buys and Sells

2026-11-03SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0025%
$62.93$220,255-0.99%
2026-10-20SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0025%
$64.01$224,035-2.78%
2026-10-06SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0028%
$61.38$214,830+1.58%
2026-09-22SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0028%
$68.29$239,015-7.05%
2026-09-08SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0027%
$75.46$264,110-15.49%
2026-08-18SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0028%
$75.82$265,370-13.62%
2026-07-21SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0028%
$80.59$282,065-12.27%
2026-07-07SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0028%
$86.62$303,170-14.58%
2026-06-23SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0028%
$79.51$278,285-7.37%
2026-06-09SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0028%
$67.98$237,930+8.28%
2026-05-19SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0028%
$75.69$264,915-3.05%
2026-05-05SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0033%
$77.37$270,795-2.7%
2026-04-21SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
3,500
0.0028%
$65.69$229,915+12.78%
2026-04-07SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
4,500
0.0036%
$65.11$292,985+12.48%
2026-03-17SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
12,033
0.0098%
$62.15$747,851+15.41%
2026-03-09SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
2,907
0.0024%
$60.72$176,513+13.98%
2025-12-16SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
2,200
0.0018%
$61.24$134,728+6.82%
2025-12-02SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
2,200
0.0019%
$63.89$140,558+3.78%
2025-11-18SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
2,200
0.0019%
$66.45$146,190-0.27%
2025-11-04SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
2,295
0.0018%
$59.55$136,667+10.58%
Total: 125
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.